EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS

Although being used for years in the treatment of tuberculosis, no data are available in the literature on the safety of pyrazinamide during pregnancy. Accordingly, we aimed to make a first approach to this problem by evaluating the effects of this drug administered during the entire pregnancy of al...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pascale Quintino,Marisa, Simões,Manuel de Jesus, Uchiyama Nakamura,Mary, Martins Oliveira-Filho,Ricardo, Espiridião,Silvia, Kulay Júnior,Luiz
Lenguaje:English
Publicado: Sociedad Chilena de Anatomía 2003
Materias:
Rat
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022003000400007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-95022003000400007
record_format dspace
spelling oai:scielo:S0717-950220030004000072004-04-02EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATSPascale Quintino,MarisaSimões,Manuel de JesusUchiyama Nakamura,MaryMartins Oliveira-Filho,RicardoEspiridião,SilviaKulay Júnior,Luiz Pyrazinamide Toxicology Rat Pregnancy Although being used for years in the treatment of tuberculosis, no data are available in the literature on the safety of pyrazinamide during pregnancy. Accordingly, we aimed to make a first approach to this problem by evaluating the effects of this drug administered during the entire pregnancy of albino rats. Fourty female, EPM-1 Wistar albino rats of about 250 g b.w. were used. Upon conception (day zero of pregnancy) the animals were randomly divided in 4 groups of 10 rats each and labeled as follows. Controls (C), animals treated with the drug vehicle (destilled water); experimental groups (E1, E2 and E3), animals treated with 35, 105 or 315 mg/kg b.w. pyrazinamide by gavage (oral route) once daily up to the term (20th day of pregnancy). Drug or vehicle volume was always 0.5 ml. Body weight gain was followed up every week. At term, upon sacrifice (in excess of anesthesia) and histerectomy, the following parameters have been studied: number of implantations and reabsorptions; intrauterine deaths; number of living foetuses and of placentae; weights of concepts and of placentae; major foetal malformations; maternal mortality index. No significant effects of pyrazinamide on rat pregnancy have been observed regarding the maternal body weight gain, the weights of concepts, the number of implantations and reabsorptions and the weights of placentae and foetuses. Also, no deleterious effects have been noticed regarding major foetal malformations, intrauterine deaths or maternal mortality. With the highest pyrazinamide dosis employed (315 mg/kg b.w.), however, a significant lowered uterine weight was recorded. Although otherwise safe, a high-dose regimen of pyrazinamide during rat pregnancy can induce a slight yet significant reduction of uterine weight.info:eu-repo/semantics/openAccessSociedad Chilena de AnatomíaInternational Journal of Morphology v.21 n.4 20032003-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022003000400007en10.4067/S0717-95022003000400007
institution Scielo Chile
collection Scielo Chile
language English
topic Pyrazinamide
Toxicology
Rat
Pregnancy
spellingShingle Pyrazinamide
Toxicology
Rat
Pregnancy
Pascale Quintino,Marisa
Simões,Manuel de Jesus
Uchiyama Nakamura,Mary
Martins Oliveira-Filho,Ricardo
Espiridião,Silvia
Kulay Júnior,Luiz
EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS
description Although being used for years in the treatment of tuberculosis, no data are available in the literature on the safety of pyrazinamide during pregnancy. Accordingly, we aimed to make a first approach to this problem by evaluating the effects of this drug administered during the entire pregnancy of albino rats. Fourty female, EPM-1 Wistar albino rats of about 250 g b.w. were used. Upon conception (day zero of pregnancy) the animals were randomly divided in 4 groups of 10 rats each and labeled as follows. Controls (C), animals treated with the drug vehicle (destilled water); experimental groups (E1, E2 and E3), animals treated with 35, 105 or 315 mg/kg b.w. pyrazinamide by gavage (oral route) once daily up to the term (20th day of pregnancy). Drug or vehicle volume was always 0.5 ml. Body weight gain was followed up every week. At term, upon sacrifice (in excess of anesthesia) and histerectomy, the following parameters have been studied: number of implantations and reabsorptions; intrauterine deaths; number of living foetuses and of placentae; weights of concepts and of placentae; major foetal malformations; maternal mortality index. No significant effects of pyrazinamide on rat pregnancy have been observed regarding the maternal body weight gain, the weights of concepts, the number of implantations and reabsorptions and the weights of placentae and foetuses. Also, no deleterious effects have been noticed regarding major foetal malformations, intrauterine deaths or maternal mortality. With the highest pyrazinamide dosis employed (315 mg/kg b.w.), however, a significant lowered uterine weight was recorded. Although otherwise safe, a high-dose regimen of pyrazinamide during rat pregnancy can induce a slight yet significant reduction of uterine weight.
author Pascale Quintino,Marisa
Simões,Manuel de Jesus
Uchiyama Nakamura,Mary
Martins Oliveira-Filho,Ricardo
Espiridião,Silvia
Kulay Júnior,Luiz
author_facet Pascale Quintino,Marisa
Simões,Manuel de Jesus
Uchiyama Nakamura,Mary
Martins Oliveira-Filho,Ricardo
Espiridião,Silvia
Kulay Júnior,Luiz
author_sort Pascale Quintino,Marisa
title EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS
title_short EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS
title_full EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS
title_fullStr EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS
title_full_unstemmed EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS
title_sort effects of pyrazinamide on pregnant albino rats
publisher Sociedad Chilena de Anatomía
publishDate 2003
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022003000400007
work_keys_str_mv AT pascalequintinomarisa effectsofpyrazinamideonpregnantalbinorats
AT simoesmanueldejesus effectsofpyrazinamideonpregnantalbinorats
AT uchiyamanakamuramary effectsofpyrazinamideonpregnantalbinorats
AT martinsoliveirafilhoricardo effectsofpyrazinamideonpregnantalbinorats
AT espiridiaosilvia effectsofpyrazinamideonpregnantalbinorats
AT kulayjuniorluiz effectsofpyrazinamideonpregnantalbinorats
_version_ 1718444552271953920